Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2002 | 06-2002 | 03-2002 | 12-2001 | 09-2001 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 120 | 180 | 320 | 60 | 160 |
| TOTAL | $120 | $180 | $320 | $60 | $160 |
| Non-Current Assets | |||||
| PPE Net | 890 | 460 | 390 | 380 | 410 |
| TOTAL | $890 | $460 | $390 | $380 | $410 |
| Total Assets | $1,010 | $640 | $710 | $440 | $570 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,430 | 610 | 430 | 1,150 | 210 |
| Accrued Expenses | 4,300 | 3,190 | 2,240 | 2,360 | 2,890 |
| Other current liabilities | 240 | 250 | 0 | 430 | 430 |
| TOTAL | $5,970 | $4,050 | $2,670 | $3,940 | $3,530 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,970 | $4,050 | $2,670 | $3,940 | $3,530 |
| Shareholders' Equity | |||||
| Common Shares | 100 | 100 | 100 | 100 | 80 |
| TOTAL | $73,730 | $73,250 | $72,940 | $72,460 | $59,250 |
| Total Liabilities And Equity | $79,700 | $77,300 | $75,610 | $76,400 | $62,780 |